BILL · 2003–04 SESSION
HB 1454: B & o tax credits
Eliminating the expiration date on certain business and occupation tax credits and deferrals.
Summary
- Extends the business and occupation (B&O) tax credit allowed to high technology businesses for certain expenditures associated with research and development (R&D) indefinitely.
- Extends the sales and use tax deferral/exemption for certain expenditures associated with R&D and pilot scale manufacturing indefinitely.
From the House Bill Analysis (HB 1454), written by the Legislature's nonpartisan staff. Read the full report ↗
Did not pass Did not pass · stalled on the House floor
- IntroducedJan 27, 2003
- Out of committeeMar 10, 2003
- Passed Housestopped here
- Passed Senate
- Governor
- Law
- Prime sponsor
- Jeff Morris (D-40)
- Introduced
- January 27, 2003 in the House
- Last action
- January 14, 2004
- Budget
- Has a fiscal note
AN ACT Relating to business and occupation tax credits and deferrals for research and development and high technology job creation;
Sponsors
Prime sponsor: Jeff Morris (D-40)
24 co-sponsors (10 Democrats, 14 Republicans)
Jack Cairnes R-47Jeff Gombosky D-3Roger Bush R-2Al O'Brien D-1Kelli Linville D-42Glenn Anderson R-5Steve Kirby D-29Rodney Tom R-48Bill Grant D-16Lynn Kessler D-24Brian Sullivan D-21Dan Roach R-31Brad Benson R-6Daniel Newhouse R-15Bruce Chandler R-15Ed Orcutt R-18Toby Nixon R-45Beverly Woods R-23Phil Rockefeller D-23Lois McMahan R-26Tom Campbell R-2Cheryl Pflug R-5Dave Upthegrove D-33Laura Ruderman D-45
Votes
No recorded floor votes.
History
- House Rules "X" file.
- By resolution, reintroduced and retained in present status.
- By resolution, reintroduced and retained in present status.
- By resolution, reintroduced and retained in present status.
- Passed to Rules Committee for second reading.
- Minority; do not pass.
- FIN - Majority; do pass.
- FIN - Executive action taken by committee.
- First reading, referred to Finance.
HB 1454 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- HB 1454 (2025–26) Drug task force funding
- HB 1454 (2023–24) Competitive telecomm.
- HB 1454 (2021–22) Unlicensed child care
- HB 1454 (2019–20) Students with disabilities
- HB 1454 (2017–18) Eminent domain/economic dev.
- HB 1454 (2015–16) Industrial insurnce benefits
- HB 1454 (2013–14) Freedom of travel act
- HB 1454 (2011–12) Bloodborne pathogen testing